Have a personal or library account? Click to login
Exploring adherence in patients with advanced breast cancer: focus on CDK4/6 inhibitors Cover

Exploring adherence in patients with advanced breast cancer: focus on CDK4/6 inhibitors

Acta Pharmaceutica
Volume 73 (2023): Issue 4 (December 2023)
By: Matea Baković,  Martina Bago,  Lucija Benić,  Magdalena Krajinović,  Tajana Silovski,  Natalija Dedić Plavetić,  Lu Turković,  Miranda Sertić and  Maja Ortner Hadžiabdić  
Open Access
|Dec 2023
DOI: https://doi.org/10.2478/acph-2023-0045 | Journal eISSN: 1846-9558 | Journal ISSN: 1330-0075
Journal RSS Feed
Language: English
Page range: 633 - 654
Accepted on: Nov 30, 2023
Published on: Dec 26, 2023
Published by: Croatian Pharmaceutical Society
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year
Keywords:
advanced breast cancer,
oral anticancer therapy,
CDK 4/6 inhibitors,
adherence,
depressive symptoms,
beliefs about medicines
Related subjects:
Pharmacy,
Pharmacy, other

© 2023 Matea Baković, Martina Bago, Lucija Benić, Magdalena Krajinović, Tajana Silovski, Natalija Dedić Plavetić, Lu Turković, Miranda Sertić, Maja Ortner Hadžiabdić, published by Croatian Pharmaceutical Society
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.

Previous articleVolume 73 (2023): Issue 4 (December 2023)Next article